Hepatocellular carcinoma

Results: 2014



#Item
21Euro Hepatitis Index 2012 Report

Euro Hepatitis Index 2012 Report

Add to Reading List

Source URL: www.healthpowerhouse.com

Language: English - Date: 2016-06-08 15:34:48
22EUROCARE-5 on-line database Data and methods Extract from “Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study” De Angelis R, Sant M, Coleman MP, Francisci S, Ba

EUROCARE-5 on-line database Data and methods Extract from “Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study” De Angelis R, Sant M, Coleman MP, Francisci S, Ba

Add to Reading List

Source URL: w3.iss.it

Language: English - Date: 2014-02-28 13:29:53
23jogging shoes with detailed clipping path

jogging shoes with detailed clipping path

Add to Reading List

Source URL: liver.ca

Language: English - Date: 2015-09-28 12:50:32
24Genome Informatics 11: 240–Classification of Hepatocellular Carcinoma by Gene Expression Profiling Analysis

Genome Informatics 11: 240–Classification of Hepatocellular Carcinoma by Gene Expression Profiling Analysis

Add to Reading List

Source URL: www.jsbi.org

Language: English - Date: 2001-02-21 04:08:00
25jogging shoes with detailed clipping path

jogging shoes with detailed clipping path

Add to Reading List

Source URL: www.liver.ca

Language: English - Date: 2015-09-28 12:50:32
26Repeat in 2 to 5 years: sorafenib 200 mg cipla IV: 0.2 to 0.5 mg 3 to 4 hours. Don’t stop using the drug in question. Alprazolam may be recommended as part of the type of interventions, services and hotlines. Protect y

Repeat in 2 to 5 years: sorafenib 200 mg cipla IV: 0.2 to 0.5 mg 3 to 4 hours. Don’t stop using the drug in question. Alprazolam may be recommended as part of the type of interventions, services and hotlines. Protect y

Add to Reading List

Source URL: milfordk12.org

Language: English - Date: 2016-08-19 10:20:15
27VIRAL HEPATITIS C IN THALASSAEMIA ENDORSED BY: THE EUROPEAN ASSOCIATION FOR THE STUDY OF LIVER (EASL)

VIRAL HEPATITIS C IN THALASSAEMIA ENDORSED BY: THE EUROPEAN ASSOCIATION FOR THE STUDY OF LIVER (EASL)

Add to Reading List

Source URL: www.ukts.org

Language: English - Date: 2016-07-02 14:51:32
28what is sorafenib. sorafenib tyrosine kinase sorafenib sunitinib everolimus. sorafenib rad001 tipifarnib sorafenib sorafenib bayer sorafenib patient comments. sorafenib dosage. il-2 and sorafenib versus sorafenib trial p

what is sorafenib. sorafenib tyrosine kinase sorafenib sunitinib everolimus. sorafenib rad001 tipifarnib sorafenib sorafenib bayer sorafenib patient comments. sorafenib dosage. il-2 and sorafenib versus sorafenib trial p

Add to Reading List

Source URL: observantnomad.com

Language: English - Date: 2016-08-18 20:00:51
29Last updated: 5 AprilCorrigenda to the IARC Monographs – Volume 112 Monograph Section

Last updated: 5 AprilCorrigenda to the IARC Monographs – Volume 112 Monograph Section

Add to Reading List

Source URL: monographs.iarc.fr

Language: English - Date: 2016-04-05 05:36:00
30Bristol-Myers Squibb and ZAI Lab Enter Licensing Agreement to Develop, Manufacture and Commercialize Brivanib in China SHANGHAI) – Bristol-Myers Squibb Company (NYSE: BMY) and ZAI Lab Limited (ZAI Lab), a le

Bristol-Myers Squibb and ZAI Lab Enter Licensing Agreement to Develop, Manufacture and Commercialize Brivanib in China SHANGHAI) – Bristol-Myers Squibb Company (NYSE: BMY) and ZAI Lab Limited (ZAI Lab), a le

Add to Reading List

Source URL: www.zailaboratory.com

Language: English - Date: 2015-09-06 03:07:12